1. Home
  2. TAVIR vs BHST Comparison

TAVIR vs BHST Comparison

Compare TAVIR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAVIR
  • BHST
  • Stock Information
  • Founded
  • TAVIR N/A
  • BHST 2007
  • Country
  • TAVIR United States
  • BHST Canada
  • Employees
  • TAVIR N/A
  • BHST N/A
  • Industry
  • TAVIR
  • BHST
  • Sector
  • TAVIR
  • BHST
  • Exchange
  • TAVIR Nasdaq
  • BHST Nasdaq
  • Market Cap
  • TAVIR N/A
  • BHST N/A
  • IPO Year
  • TAVIR N/A
  • BHST N/A
  • Fundamental
  • Price
  • TAVIR $0.13
  • BHST $6.15
  • Analyst Decision
  • TAVIR
  • BHST Strong Buy
  • Analyst Count
  • TAVIR 0
  • BHST 2
  • Target Price
  • TAVIR N/A
  • BHST $13.00
  • AVG Volume (30 Days)
  • TAVIR N/A
  • BHST 8.5K
  • Earning Date
  • TAVIR N/A
  • BHST 02-15-2025
  • Dividend Yield
  • TAVIR N/A
  • BHST N/A
  • EPS Growth
  • TAVIR N/A
  • BHST N/A
  • EPS
  • TAVIR N/A
  • BHST N/A
  • Revenue
  • TAVIR N/A
  • BHST $22,430,000.00
  • Revenue This Year
  • TAVIR N/A
  • BHST N/A
  • Revenue Next Year
  • TAVIR N/A
  • BHST N/A
  • P/E Ratio
  • TAVIR N/A
  • BHST N/A
  • Revenue Growth
  • TAVIR N/A
  • BHST 111.68
  • 52 Week Low
  • TAVIR N/A
  • BHST $0.00
  • 52 Week High
  • TAVIR N/A
  • BHST $7.38
  • Technical
  • Relative Strength Index (RSI)
  • TAVIR N/A
  • BHST N/A
  • Support Level
  • TAVIR N/A
  • BHST N/A
  • Resistance Level
  • TAVIR N/A
  • BHST N/A
  • Average True Range (ATR)
  • TAVIR 0.00
  • BHST 0.00
  • MACD
  • TAVIR 0.00
  • BHST 0.00
  • Stochastic Oscillator
  • TAVIR 0.00
  • BHST 0.00

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: